BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18543076)

  • 1. Evidence on the construct validity of the Health Utilities Index Mark 2 and Mark 3 in patients with chronic kidney disease.
    Davison SN; Jhangri GS; Feeny DH
    Qual Life Res; 2008 Aug; 17(6):933-42. PubMed ID: 18543076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal construct validity of the Health Utilities Indices Mark 2 and Mark 3 in hip fracture.
    Jones CA; Pohar SL; Feeny DH; Eng K
    Qual Life Res; 2014 Apr; 23(3):805-13. PubMed ID: 24081869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of HUI2 and HUI3 utility scores in Alzheimer's disease.
    Neumann PJ; Sandberg EA; Araki SS; Kuntz KM; Feeny D; Weinstein MC
    Med Decis Making; 2000; 20(4):413-22. PubMed ID: 11059474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints.
    Grutters JP; Joore MA; van der Horst F; Verschuure H; Dreschler WA; Anteunis LJ
    Qual Life Res; 2007 Oct; 16(8):1439-49. PubMed ID: 17647093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construct validity for the Health Utilities Index in a sleep center.
    Welch KC; Scharf SM
    Sleep Breath; 2007 Dec; 11(4):295-303. PubMed ID: 17457630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial.
    Raisch DW; Feeney P; Goff DC; Narayan KM; O'Connor PJ; Zhang P; Hire DG; Sullivan MD
    Cardiovasc Diabetol; 2012 Jul; 11():35. PubMed ID: 22515638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the health utilities indices Mark 2 and Mark 3 in type 2 diabetes.
    Maddigan SL; Feeny DH; Johnson JA;
    Med Decis Making; 2003; 23(6):489-501. PubMed ID: 14672109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the Health Utilities Index Mark 3 (HUI3) with the Short Form-36 preference-based SF-6D in chronic kidney disease.
    Davison SN; Jhangri GS; Feeny DH
    Value Health; 2009; 12(2):340-5. PubMed ID: 18657096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A parent-child dyad approach to the assessment of health status and health-related quality of life in children with asthma.
    Ungar WJ; Boydell K; Dell S; Feldman BM; Marshall D; Willan A; Wright JG
    Pharmacoeconomics; 2012 Aug; 30(8):697-712. PubMed ID: 22788260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutual concurrent validity of the child health questionnaire and the health utilities index: an exploratory analysis using survivors of childhood cancer.
    Nixon Speechley K; Maunsell E; Desmeules M; Schanzer D; Landgraf JM; Feeny DH; Barrera ME
    Int J Cancer Suppl; 1999; 12():95-105. PubMed ID: 10679879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness and construct validity of the health utilities index in patients with dementia.
    Kavirajan H; Hays RD; Vassar S; Vickrey BG
    Med Care; 2009 Jun; 47(6):651-61. PubMed ID: 19433998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cohort study found the RAND-12 and Health Utilities Index Mark 3 demonstrated construct validity in high-risk primary care patients.
    Feeny D; Farris K; Côté I; Johnson JA; Tsuyuki RT; Eng K
    J Clin Epidemiol; 2005 Feb; 58(2):138-41. PubMed ID: 15680746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative efficiency of the EQ-5D, HUI2, and HUI3 index scores in measuring health burden of chronic medical conditions in a population health survey in the United States.
    Luo N; Johnson JA; Shaw JW; Coons SJ
    Med Care; 2009 Jan; 47(1):53-60. PubMed ID: 19106731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing directly measured standard gamble scores to HUI2 and HUI3 utility scores: group- and individual-level comparisons.
    Feeny D; Furlong W; Saigal S; Sun J
    Soc Sci Med; 2004 Feb; 58(4):799-809. PubMed ID: 14672594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
    Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the discriminatory power of EQ-5D, HUI2 and HUI3 in a US general population survey using Shannon's indices.
    Bas Janssen MF; Birnie E; Bonsel GJ
    Qual Life Res; 2007 Jun; 16(5):895-904. PubMed ID: 17294285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. French cross-cultural adaptation of the Health Utilities Indexes Mark 2 (HUI2) and 3 (HUI3) classification systems. Clinical and Economic Working Groups.
    Costet N; Le Galès C; Buron C; Kinkor F; Mesbah M; Chwalow J; Slama G
    Qual Life Res; 1998 Apr; 7(3):245-56. PubMed ID: 9584555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construct validity of the RAND-12 and Health Utilities Index Mark 2 and 3 in type 2 diabetes.
    Maddigan SL; Feeny DH; Johnson JA;
    Qual Life Res; 2004 Mar; 13(2):435-48. PubMed ID: 15085916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the construct validity of the Health Utilities Index Mark 3 (HUI3) in patients with schizophrenia.
    Luo N; Seng BK; Thumboo J; Feeny D; Li SC
    Qual Life Res; 2006 Jun; 15(5):889-98. PubMed ID: 16721648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing short form 6D, standard gamble, and Health Utilities Index Mark 2 and Mark 3 utility scores: results from total hip arthroplasty patients.
    Feeny D; Wu L; Eng K
    Qual Life Res; 2004 Dec; 13(10):1659-70. PubMed ID: 15651537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.